Molecular docking and molecular dynamics simulation of anticancer active ligand '3,5,7,3′,5′-pentahydroxy-flavanonol-3-O-α-L-rhamnopyranoside' from Bauhinia strychnifolia Craib to the cyclin-dependent protein kinase

被引:10
作者
Ali, Mohammad Ajmal [1 ]
机构
[1] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia
关键词
Molecular docking; Molecular docking simulation; 3,5,7,3',5'-pentahydroxy-flavanonol-3-O-alpha-L-rhamnopyranoside; Bauhinia strychnifolia Craib; Fabaceae; Cyclin-dependent protein kinase 2; COMBINATION; STATISTICS; EFFICIENT; INSIGHTS; THERAPY; PROVIDE;
D O I
10.1016/j.jksus.2019.05.004
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The compound '3,5,7,3',5'-pentahydroxy-flavanonol-3-O-alpha-L-rhamnopyranoside' reported from Bauhinia strychnifolia Craib (family Fabaceae) possess ten times more cytotoxicity against certain cancer cell line than the anti-cancer drugs, but nontoxic to normal cells. Its stability with the protein 'cyclindependent protein kinase 2/CDK-2' (-which plays vital role in apoptosis, regulation of the cell cycle, transcription and in the neuronal functions) were performed via molecular docking and molecular dynamics simulation simulations. The molecular dynamics simulation suggests that the protein-ligand complex is stable at least in the time period of 40 ns. This study also shows that after 20 ns of simulation, there is a shift in the ligand position, and it might be due to changes in the binding type. According to the data obtained via MM-PBSA calculations, this shift leads to even stronger binding of ligand. Such binding flexibility can be explained by highly hydrophilic nature of both ligand and binding site. (C) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:891 / 895
页数:5
相关论文
共 39 条
[1]   In vitro cytotoxicity screening of wild plant extracts from Saudi Arabia on human breast adenocarcinoma cells [J].
Ali, M. A. ;
Farah, M. Abul ;
Al-Hemaid, F. M. ;
Abou-Tarboush, F. M. .
GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) :3981-3990
[2]  
[Anonymous], THAI TRADITIONAL MED
[3]  
[Anonymous], APOLLO MED
[4]   Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[5]  
Case D.A., 2016, Amber
[6]   ACPYPE - AnteChamber PYthon Parser interfacE [J].
Alan W Sousa da Silva ;
Wim F Vranken .
BMC Research Notes, 5 (1)
[7]   Cyclin-dependent kinase inhibitors [J].
Dai, Y ;
Grant, S .
CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (04) :362-370
[8]   Molecular recognition of bio-active flavonoids quercetin and rutin by bovine hemoglobin: an overview of the binding mechanism, thermodynamics and structural aspects through multi-spectroscopic and molecular dynamics simulation studies [J].
Das, Sourav ;
Bora, Nikita ;
Rohman, Mostofa Ataur ;
Sharma, Raju ;
Jha, Anupam Nath ;
Roy, Atanu Singha .
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2018, 20 (33) :21668-21684
[9]   Deciphering the Interaction of 5,7-Dihydroxyflavone with Hen-Egg-White Lysozyme through Multispectroscopic and Molecular Dynamics Simulation Approaches [J].
Das, Sourav ;
Khanikar, Portia ;
Hazarika, Zaved ;
Rohman, Mostofa Ataur ;
Uzir, Antara ;
Jha, Anupam Nath ;
Roy, Atanu Singha .
CHEMISTRYSELECT, 2018, 3 (17) :4911-4922
[10]   Cancer Treatment and Survivorship Statistics, 2014 [J].
DeSantis, Carol E. ;
Lin, Chun Chieh ;
Mariotto, Angela B. ;
Siegel, Rebecca L. ;
Stein, Kevin D. ;
Kramer, Joan L. ;
Alteri, Rick ;
Robbins, Anthony S. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (04) :252-271